Management of hepatorenal syndrome and associated outcomes: a systematic reviews.

Jamshid RoozbehShahrokh Ezzatzadegan JahromiMohamad Hossein RezazadehAnahid HamidianjahromiLeila Malekmakan

Published in: BMJ open gastroenterology (2024)

This review showed that terlipressin has a significantly higher reversal rate of HRS than the other treatments. Even the results showed that terlipressin is more efficient than midodrine/octreotide and norepinephrine as a previous medication, in reverse HRS, increasing patient survival.

Keyphrases

case report
systematic review
healthcare
free survival
randomized controlled trial
type diabetes
metabolic syndrome
weight loss